150 related articles for article (PubMed ID: 37509533)
1. ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation.
Gesualdi L; Berardini M; Scicchitano BM; Castaldo C; Bizzarri M; Filippini A; Riccioli A; Schiraldi C; Ferranti F; Liguoro D; Mancini R; Ricci G; Catizone A
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509533
[TBL] [Abstract][Full Text] [Related]
2. The PI3K/AKT Pathway Is Activated by HGF in NT2D1 Non-Seminoma Cells and Has a Role in the Modulation of Their Malignant Behavior.
Gesualdi L; Leonetti E; Cucina A; Scicchitano BM; Sorrentino S; Tarsitano MG; Isidori A; Bizzarri M; Filippini A; Riccioli A; Cammarota M; Gigantino V; Ricci G; Catizone A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212946
[TBL] [Abstract][Full Text] [Related]
3. c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells.
Leonetti E; Gesualdi L; Scheri KC; Dinicola S; Fattore L; Masiello MG; Cucina A; Mancini R; Bizzarri M; Ricci G; Catizone A
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646583
[No Abstract] [Full Text] [Related]
4. c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors.
Scheri KC; Leonetti E; Laino L; Gigantino V; Gesualdi L; Grammatico P; Bizzari M; Franco R; Oosterhuis JW; Stoop H; Looijenga LHJ; Ricci G; Catizone A
Oncotarget; 2018 Aug; 9(61):31842-31860. PubMed ID: 30159127
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells.
Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
Cell Biochem Funct; 2014 Aug; 32(6):485-95. PubMed ID: 24964901
[TBL] [Abstract][Full Text] [Related]
8. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
9. c-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cells.
Rush S; Khan G; Bamisaiye A; Bidwell P; Leaver HA; Rizzo MT
Exp Cell Res; 2007 Jan; 313(1):121-32. PubMed ID: 17055484
[TBL] [Abstract][Full Text] [Related]
10. Blocking c-Met signaling enhances bone morphogenetic protein-2-induced osteoblast differentiation.
Shibasaki S; Kitano S; Karasaki M; Tsunemi S; Sano H; Iwasaki T
FEBS Open Bio; 2015; 5():341-7. PubMed ID: 25941631
[TBL] [Abstract][Full Text] [Related]
11. ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase.
Yu CF; Liu ZX; Cantley LG
J Biol Chem; 2002 May; 277(22):19382-8. PubMed ID: 11896055
[TBL] [Abstract][Full Text] [Related]
12. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways.
Xiao GH; Jeffers M; Bellacosa A; Mitsuuchi Y; Vande Woude GF; Testa JR
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):247-52. PubMed ID: 11134526
[TBL] [Abstract][Full Text] [Related]
13. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
[TBL] [Abstract][Full Text] [Related]
14. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
Menakongka A; Suthiphongchai T
World J Gastroenterol; 2010 Feb; 16(6):713-22. PubMed ID: 20135719
[TBL] [Abstract][Full Text] [Related]
15. BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro.
Dai Y; Siemann DW
Mol Cancer Ther; 2010 Jun; 9(6):1554-61. PubMed ID: 20515943
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells.
Uruno A; Sugawara A; Kanatsuka H; Arima S; Taniyama Y; Kudo M; Takeuchi K; Ito S
Hypertens Res; 2004 Nov; 27(11):887-95. PubMed ID: 15824471
[TBL] [Abstract][Full Text] [Related]
17. High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2.
Tsukada Y; Miyazawa K; Kitamura N
J Biol Chem; 2001 Nov; 276(44):40968-76. PubMed ID: 11533045
[TBL] [Abstract][Full Text] [Related]
18. Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607.
Dai Y; Siemann DW
BMC Cancer; 2012 May; 12():198. PubMed ID: 22639908
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma inhibits hepatocyte growth factor-stimulated cell proliferation of human bronchial epithelial cells: upregulation of p27(kip1) cyclin-dependent kinase inhibitor.
Takami K; Takuwa N; Okazaki H; Kobayashi M; Ohtoshi T; Kawasaki S; Dohi M; Yamamoto K; Nakamura T; Tanaka M; Nakahara K; Takuwa Y; Takizawa H
Am J Respir Cell Mol Biol; 2002 Feb; 26(2):231-8. PubMed ID: 11804875
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK/MAPK and Zeb-1 signaling pathway.
Han Y; Luo Y; Wang Y; Chen Y; Li M; Jiang Y
Oncol Lett; 2016 Jan; 11(1):753-759. PubMed ID: 26870279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
